Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Guerra

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
JCI Insight|October 17, 2024
NK cell subsets define sustained remission in rheumatoid arthritisCarl Coyle, Margaret Ma, Yann Abraham, et al.
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Immunity|April 9, 2008
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancyNadia Guerra, Ying Xim Tan, Nathalie T Joncker, et al.
Microbiome|February 28, 2025
Roux-en-Y gastric bypass-associated fecal tyramine promotes colon cancer risk via increased DNA damage, cell proliferation, and inflammationMaria Glymenaki, Sophie Curio, Smeeta Shrestha, et al.
Nature Communications|October 7, 2024
The activating receptor NKG2D is an anti-fungal pattern recognition receptorYoav Charpak-Amikam, Mark Kournos, Rebecca Kotzur, et al.
Discovery Immunology|October 24, 2022
NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progressionSophie Curio, Sarah C Edwards, Toshiyasu Suzuki, et al.
Journal of Hepatology|January 23, 2021
Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressivenessMathilde Cadoux, Stefano Caruso, Sandrine Pham, et al.
Immunity|November 21, 2020
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint BlockadeEduardo Bonavita, Christian P Bromley, Gustav Jonsson, et al.
Journal of Hepatology|June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinomaPasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JCI Insight|October 17, 2024
NK cell subsets define sustained remission in rheumatoid arthritisCarl Coyle, Margaret Ma, Yann Abraham, et al.
Oncogene|March 12, 2020
Immune-based therapies for hepatocellular carcinomaDavid J Pinato, Nadia Guerra, Petros Fessas, et al.
Immunity|April 9, 2008
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancyNadia Guerra, Ying Xim Tan, Nathalie T Joncker, et al.
Microbiome|February 28, 2025
Roux-en-Y gastric bypass-associated fecal tyramine promotes colon cancer risk via increased DNA damage, cell proliferation, and inflammationMaria Glymenaki, Sophie Curio, Smeeta Shrestha, et al.
Nature Communications|October 7, 2024
The activating receptor NKG2D is an anti-fungal pattern recognition receptorYoav Charpak-Amikam, Mark Kournos, Rebecca Kotzur, et al.
Discovery Immunology|October 24, 2022
NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progressionSophie Curio, Sarah C Edwards, Toshiyasu Suzuki, et al.
Journal of Hepatology|January 23, 2021
Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressivenessMathilde Cadoux, Stefano Caruso, Sandrine Pham, et al.
Immunity|November 21, 2020
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint BlockadeEduardo Bonavita, Christian P Bromley, Gustav Jonsson, et al.
Journal of Hepatology|June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinomaPasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
Pageof 3